Filter News

El Paso, Inc.: How the dental school deal was done

September 1, 2016

Six months ago, El Paso businessman and philanthropist Woody Hunt was in a meeting with Texas Tech officials. Read the full story at El Paso, Inc.


Xconomy: For Fledgling San Antonio Companies, Startup Resources Trickling In

September 1, 2016

Echolase, a young startup with a product that crosses over between technology and life sciences, is on the brink of getting its first outside funding from a local investment group. Read the full story at Xconomy


DVIDS: Texas A&M-San Antonio holds 9/11 Heroes Run

September 1, 2016

Texas A&M University-San Antonio hosted the 9/11 Heroes Run event to commemorate the 15th anniversary of the terrorist attacks on the World Trade Center buildings Sept. 11, 2016 on the A&M-SA campus. Read the full story at DVIDS


KSAT 12: Study: HIV positive Hispanics have higher risk of obesity, diabetes

September 1, 2016

Having spent 15 years working in the Dominican Republic among Hispanics living with HIV, Dr. Barbara Taylor, an expert in infectious diseases, said her latest study shows there’s an increased risk for obesity and diabetes. Watch the full story at KSAT …


UTSA Today: UTSA to host international conference on Latino aging in the Americas Sept. 14-16

September 1, 2016

The UTSA College of Public Policy (COPP) will serve as host of the 2016 International Conference on Aging in the Americas (ICAA) on Sept. 14-16 at the Downtown Campus. The conference is free and open to the public. Read the full story at UTSA Today


Texas Public Radio: UTSA Lab Developing New Treatment For Aneurysms

September 1, 2016

A professor with the University of Texas at San Antonio is trying to come up with a new way to treat a deadly health problem: abdominal aortic aneurysms. Read the full story at Texas Public Radio


The University of Texas System: UT Horizon Fund invests $150K to fund medical device that repairs blood vessels

September 1, 2016

The UT Horizon Fund recently invested $150,000 to fund Cardiovate, a San Antonio-based startup that is using technology from two University of Texas System institutions to commercialize a medical device to treat vascular diseases by repairing blood ves …


MedPage Today: Triple Combo Tx Durable for T2D

September 1, 2016

Starting newly-diagnosed diabetes patients on the triple combination of metformin/pioglitazone/exenatide upfront provided better glucose control with less hypoglycemia than a standard sequential regimen, 3-year follow-up from the EDICT trial showed. Re …


UTSA Today: UTSA alumna’s medical device receives UT System investment

September 1, 2016

The UT Horizon Fund recently invested $150,000 to fund Cardiovate, a San Antonio-based startup that is using technology from two University of Texas System institutions to commercialize a medical device to treat vascular diseases by repairing blood ves …


Undark Magazine: Rethinking Prostate Cancer Treatments

September 1, 2016

In an outcome likely to raise broad questions about aggressive prostate cancer treatment, a randomized study of 1,643 British men found that, roughly 10 years after a prostate cancer diagnosis, the vast majority of participants had survived the cancer …


Filter news